According to me, I think at the moment 0.3 seems to be a fair valuation for AT1 at the moment, they sold shares at 0.2 and it went up after their deal with NG biotech. Their next deal would push it up a little and then it may drop down to around 0.4.
But in the long run it would definitely cross 1$
According to me, I think at the moment 0.3 seems to be a fair...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 895300 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 153126 | 3 |
View Market Depth
| Last trade - 10.28am 10/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |
Day chart unavailable